Evidence map›Paper›PMID 26804990›Full record

ArticleNeuron2016

Rabies Virus CVS-N2c(ΔG) Strain Enhances Retrograde Synaptic Transfer and Neuronal Viability.

Thomas R Reardon, Andrew J Murray, Gergely F Turi, Christoph Wirblich, Katherine R Croce, Matthias J Schnell, Thomas M Jessell, Attila Losonczy

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 203 papers.

0numbers the graph read from it
0cells of the map it votes in
203citing papers in PubMed
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

203 citing papers in PubMed, 334 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

143 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Thomas R ReardonDepartments of Neuroscience and Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, New York, NY 10032, USA.
Andrew J MurrayDepartments of Neuroscience and Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, New York, NY 10032, USA. Electronic address: a.murray@ucl.ac.uk.
Gergely F TuriDepartment of Neuroscience, Columbia University, New York, NY 10032, USA.
Christoph WirblichDepartment of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Katherine R CroceDepartments of Neuroscience and Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, New York, NY 10032, USA.
Matthias J SchnellDepartment of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Thomas M JessellDepartments of Neuroscience and Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, New York, NY 10032, USA; Kavli Institute for Brain Science, Columbia University, New York, NY 10032, USA. Electronic address: tmj1@columbia.edu.
Attila LosonczyDepartment of Neuroscience, Columbia University, New York, NY 10032, USA; Kavli Institute for Brain Science, Columbia University, New York, NY 10032, USA.
Howard Hughes Medical Institute · USColumbia University · USThomas Jefferson University · US

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
ResourceP40OD010996 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STRICK, PETER · 2012 to 2024
$11.0M
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccineR01AI105204 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SCHNELL, MATTHIAS JOHANNES · 2013 to 2017
$5.0M
CONTROL OF MOTOR NEURON DIFFERENTIATIONR01NS033245 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI JESSELL, THOMAS M. · 1994 to 2009
$3.3M
CONTROL OF MOTOR NEURON DIFFERENTIATIONR37NS033245 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JESSELL, THOMAS M. · 2010 to 2016
$2.4M
Cadherin-Catenin Based Recognition in Sensory-Motor ConnectivityR01NS080932 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WICHTERLE, HYNEK · 2013 to 2017
$1.7M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA056036NIAID NIH HHS R01 AI105204NIH HHS 5P40OD010996-10NIH HHS P40 OD010996NINDS NIH HHS NS0332245NINDS NIH HHS R01 NS033245NINDS NIH HHS R01 NS080932NINDS NIH HHS R37 NS033245
6 · The paper itself

Abstract

Virally based transsynaptic tracing technologies are powerful experimental tools for neuronal circuit mapping. The glycoprotein-deletion variant of the SAD-B19 vaccine strain rabies virus (RABV) has been the reagent of choice in monosynaptic tracing, since it permits the mapping of synaptic inputs to genetically marked neurons. Since its introduction, new helper viruses and reagents that facilitate complementation have enhanced the efficiency of SAD-B19(ΔG) transsynaptic transfer, but there has been little focus on improvements to the core RABV strain. Here we generate a new deletion mutant strain, CVS-N2c(ΔG), and examine its neuronal toxicity and efficiency in directing retrograde transsynaptic transfer. We find that by comparison with SAD-B19(ΔG), the CVS-N2c(ΔG) strain exhibits a reduction in neuronal toxicity and a marked enhancement in transsynaptic neuronal transfer. We conclude that the CVS-N2c(ΔG) strain provides a more effective means of mapping neuronal circuitry and of monitoring and manipulating neuronal activity in vivo in the mammalian CNS.

Indexed as

Action PotentialsAnimalsCells, CulturedElectric StimulationGlycoproteinsHumansLuminescent ProteinsMiceMice, Inbred C57BLMice, TransgenicNerve NetNeural PathwaysNeuroblastomaNeuronsOptogeneticsProtein Transportfluorescent protein 583GlycoproteinsLuminescent ProteinsViral Envelope Proteins

Identifiers

PMID26804990
PMCPMC4760870
OpenAlexW2256675298

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.